Latest news on Laboratorytalk categorised by supplier
Britannia Pharmaceuticals
Address:
44-51 Brighton Road
Redhill
RH1 6YS
UK
Telephone: (UK) +44 1737 773741
http://www.britannia-pharm.co.uk
Our RSS feed for news from Britannia Pharmaceuticals
Request to receive our free email newsletter each week
Listing of all 7 news releases from Britannia Pharmaceuticals:
Novel asthma treatment comes closer to market
Dry powder synthetic surfactant which shows promise for prophylactic treatment of seasonal allergic asthma and other respiratory conditions to get further development
News from Britannia Pharmaceuticals (15 November 2004)
Automimmune treatment for the UK
Novel treatment for inflammatory related diseases provides a significant alternative to other pharmaceutical therapies
News from Britannia Pharmaceuticals (19 April 2004)
2003 'a landmark year'
Britannia closes 2003 with several new partnership agreements and significant clinical progress, and aims for strategic partnerships to further develop innovative powder treatment for asthma
News from Britannia Pharmaceuticals (27 January 2004)
Bringing drug addiction treatment to the USA
Lofexidine is the only non-opiate, non-addictive treatment approved in the United Kingdom used to manage withdrawal symptoms in patients undergoing opiate detoxification
News from Britannia Pharmaceuticals (21 November 2003)
Advancing development of surgical adhesions
AdSurf is a synthetic surfactant - a unique formulation of the naturally occurring phospholipids dipalmitoylphosphatidycholine and phosphatidyl glycerol
News from Britannia Pharmaceuticals (17 October 2003)
Migraine treatment gets up your nose
Britannia and Novartis collaborate to develop nasal powder treatment for migraines which promises fast, long-lasting relief
News from Britannia Pharmaceuticals ( 9 October 2003)
Asthma treatment shows promise in phase II trial
Study published in European Respiratory Journal shows Britannia Pharmaceutical's Pumactant abolished early asthmatic responses in all subjects
News from Britannia Pharmaceuticals (16 June 2003)
